Atrial Fibrillation, An Issue of Cardiology Clinics, 1st Edition
Author :
By Ranjan K. Thakur, MD, MPH, MBA, FHRS and Andrea Natale, MD, FACC, FHRS
Atrial fibrillation (AF) is the most common sustained arrhythmia, affecting approximately 2.3 million people in the US. One of the most serious side effects of AF is embolic stroke. Technology developed in the last 10 years has made AF treatable and
...view more
Atrial fibrillation (AF) is the most common sustained arrhythmia, affecting approximately 2.3 million people in the US. One of the most serious side effects of AF is embolic stroke. Technology developed in the last 10 years has made AF treatable and potentially curable. This issue discusses many of the clinical issues in the management of AF, including cardioversion, anticoagulation, and ablation. Also included are current guidelines for treatment and a view of the future.
Atrial fibrillation (AF) is the most common sustained arrhythmia, affecting approximately 2.3 million people in the US. One of the most serious side effects of AF is embolic stroke. Technology developed in the last 10 years has made AF treatable and potentially curable. This issue discusses many of the clinical issues in the management of AF, including cardioversion, anticoagulation, and ablation. Also included are current guidelines for treatment and a view of the future.
Author Information
By Ranjan K. Thakur, MD, MPH, MBA, FHRS, Clinical Professor of Medicine, Michigan State University, Lansing, Michigan and Andrea Natale, MD, FACC, FHRS, Texas Cardiac Arrhythmias Institute, Austin, TX at St. David's Medical Center
By Ranjan K. Thakur, MD, MPH, MBA, FHRS, Clinical Professor of Medicine, Michigan State University, Lansing, Michigan and Andrea Natale, MD, FACC, FHRS, Texas Cardiac Arrhythmias Institute, Austin, TX at St. David's Medical Center
https://www.asia.elsevierhealth.com/atrial-fibrillation-an-issue-of-cardiology-clinics-9781437704563.html306757Atrial Fibrillation, An Issue of Cardiology Clinicshttps://www.asia.elsevierhealth.com/media/catalog/product/https://www.asia.elsevierhealth.com/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.png89.0998.99USDInStock/Medicine/Cardiology/Clinics/Clinics/Medicine/Cardiology/Japan Titles5054569505466652550415259850526316014886536505455351451205259833Atrial fibrillation (AF) is the most common sustained arrhythmia, affecting approximately 2.3 million people in the US. One of the most serious side effects of AF is embolic stroke. Technology developed in the last 10 years has made AF treatable and potentially curable. This issue discusses many of the clinical issues in the management of AF, including cardioversion, anticoagulation, and ablation. Also included are current guidelines for treatment and a view of the future. Atrial fibrillation (AF) is the most common sustained arrhythmia, affecting approximately 2.3 million people in the US. One of the most serious side effects of AF is embolic stroke. Technology developed in the last 10 years has made AF treatable and potentially curable. This issue discusses many of the clinical issues in the management of AF, including cardioversion, anticoagulation, and ablation. Also included are current guidelines for treatment and a view of the future.00add-to-cart97814377045632011 and earlierProfessionalBy Ranjan K. Thakur, MD, MPH, MBA, FHRS and Andrea Natale, MD, FACC, FHRS20091Book178w x 254h (7.00" x 10.00")Saunders240Jan 28, 2009IN STOCKBy <STRONG>Ranjan K. Thakur</STRONG>, MD, MPH, MBA, FHRS, Clinical Professor of Medicine, Michigan State University, Lansing, Michigan and <STRONG>Andrea Natale</STRONG>, MD, FACC, FHRS, Texas Cardiac Arrhythmias Institute, Austin, TX at St. David's Medical CenterClinicsClinicsThe Clinics: Internal MedicineUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select
